Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001211060-26-000005·Chemomab Therapeutics Ltd.
Schedule 13G ownership disclosure
CHEMOMAB THERAPEUTICS LTD
Ordinary shares, no par value per share · CUSIP: 16385C203
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Peter Thiel
Shares: 22,631,200.00 · Class: 4.6%
- Rivendell Investments 2017-9 LLC
Shares: 22,631,200.00 · Class: 4.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001211060-26-000005
- Form type
- SCHEDULE 13G/A
- Filer
- Chemomab Therapeutics Ltd.
- CIK
- CIK 1534248
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership